NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
November 4, 2025 — American Lung Association report shows critically low lung cancer screening rates despite 20% of cancer deaths. Survival rates improving to 26.6% with new treatments from companies like Calidi Biotherapeutics.
November 4, 2025 — American Heart Association names 5 health tech finalists developing AI, wearable, and digital solutions to combat heart disease and stroke, the world's leading causes of death.
November 4, 2025 — GeoVax Labs announces Q3 2025 financial results and business update, highlighting COVID-19 vaccine trials for immunocompromised patients and oncology therapies.
November 4, 2025 — American Heart Association's CarePlan Challenge winners showcase AI-powered digital health solutions for cardiovascular care, integrating CarePlans and PREVENT tools to transform patient outcomes.
November 4, 2025 — Maryland faces triple crisis: Chesapeake Bay ecosystem collapse over menhaden, SNAP benefits battle during shutdown, and major energy policy shifts affecting power generation and offshore wind projects.
November 4, 2025 — Pacylex & Heidelberg Pharma reveal zelenirstat as potent ADC payload with 1000x cancer cell potency. New cancer treatment approach shows promise for breast & prostate cancers.
November 3, 2025 — Heidelberg Pharma presents new clinical data for HDP-101 ADC showing promising anti-tumor activity in multiple myeloma patients at World ADC Congress 2025.
November 3, 2025 — American Heart Association launches initiative with Kardigan to boost aortic stenosis clinical trial participation & early diagnosis through 40+ hospitals. Learn about new treatment access.
November 3, 2025 — NanoViricides presents groundbreaking antiviral platform targeting COVID, RSV & influenza. Clinical-stage company developing broad-spectrum nanoviricide drugs to prevent viral escape.
November 3, 2025 — Sapu Nano announces first-in-human trial of Sapu-003, an injectable Everolimus for breast cancer, offering higher bioavailability and efficacy. Key partners include SOCRU and Medicilon.
November 3, 2025 — Soligenix strengthens its CTCL Medical Advisory Board to advance HyBryte™ therapy development. Clinical-stage biotech company updates expert team for cutaneous T-cell lymphoma treatment program.
November 3, 2025 — LogicMark CEO discusses company's SaaS growth strategy and innovation in personal emergency response systems. Learn how their Connected Care Platform protects at-risk populations.
November 3, 2025 — LogicMark CEO Chia-Lin Simmons discusses the company's personal emergency response systems and connected care platform for seniors and at-risk populations on Benzinga All-Access.
November 3, 2025 — GeoVax Labs relocates corporate HQ and labs to Atlanta to accelerate cancer therapies and vaccine development. Clinical-stage biotech expands in Georgia's bio-ecosystem for market readiness.
November 3, 2025 — ABVC BioPharma reports 230% revenue growth in Q3 2025, with $11M Taiwan land acquisitions for manufacturing expansion and clinical pipeline advancement in CNS and oncology.
November 3, 2025 — New research shows CPR within 5 minutes nearly doubles child survival after cardiac arrest. Study reveals children have half the time window of adults for successful intervention.
November 3, 2025 — New study shows optimal cardiovascular health reduces dementia risk in Type 2 diabetes patients, even with high genetic risk. Life's Essential 8 metrics protect brain function.
November 3, 2025 — New study reveals hidden heart dysfunction triples stroke risk in cardiac amyloidosis patients. Noninvasive tool may identify high-risk individuals for preventive treatment.
November 3, 2025 — New study links long-term melatonin use to 90% higher heart failure risk in insomnia patients. Research finds increased hospitalization and mortality with extended melatonin supplement use.
November 3, 2025 — Study finds low-dose aspirin reduces heart attack and stroke risk in Type 2 diabetes patients with cardiovascular risk. Research shows 42% lower heart attack rates among aspirin users.